The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
“同一健康联盟”：一项评估M032（一种表达IL-12的基因工程HSV-1）联合免疫检查点抑制剂治疗犬散发性高级别胶质瘤的I期临床试验设计
期刊:Frontiers in Surgery
影响因子:1.8
doi:10.3389/fsurg.2020.00059
Chambers, M R; Bentley, R Timothy; Crossman, David K; Foote, Jeremy B; Koehler, Jey W; Markert, James M; Omar, Nidal B; Platt, Simon R; Self, D Mitchell; Shores, Andy; Sorjonen, Donald C; Waters, Alicia M; Yanke, Amy B; Gillespie, G Yancey
Checkpoint
胶质瘤
Canine
免疫/内分泌
